Cryomarex Rispens
Cryomarex Rispens
Not authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Product identification
Medicine name:
Cryomarex Rispens
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live10000.00/plaque forming unit1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- (glass) ampoule of 1,000 doses of vaccine, 5-ampoule carrier, 5-carrier canister, liquid nitrogen container for 1 to 6 canisters.
- (glass) ampoule of 1,000 doses of vaccine, 5-ampoule carrier, 16-carrier canister, liquid nitrogen container for 1 to 6 canisters.
- (glass) ampoule of 1,000 doses of vaccine, 5-ampoule carrier, 21-carrier canister, liquid nitrogen container for 10 canisters
- (glass) ampoule of 2,000 doses of vaccine, 5-ampoule carrier, 5-carrier canister, liquid nitrogen container for 1 to 6 canisters.
- (glass) ampoule of 2,000 doses of vaccine, 5-ampoule carrier, 16-carrier canister, liquid nitrogen container for 1 to 6 canisters.
- (glass) ampoule of 2,000 doses of vaccine, 5-ampoule carrier, 21-carrier canister, liquid nitrogen container for 10 canisters.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10454/030/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024